Category Archives: Dubious statistics

Financialization of the U.S. Pharmaceutical Industry

A takedown of the pharmaceutical industry’s assertion that it need to price gouge so it can invest in R&D. Profits go almost entirely to various forms of looting.

Read more...

Private Equity’s Uninvested “Dry Powder” and Falling Returns Reflect a Bigger Problem: The End of a Long Term Disinflationary Tail Wind

The press is finally becoming skeptical of private equity’s claims that it generates superior returns, demonstrated by a Monday Wall Street Journal story, Private-Equity Cash Piles Up as Takeover Targets Get Pricier1 and a Bloomberg article yesterday, ‘Peak’ Private-Equity Fears Are Spreading Across Pension World. This follows a Mark Hulbert piece in MarketWatch, whose title […]

Read more...